Caspase-1 activation and a predominant IL-1/IL-6 signature associated with IFNγ-induced chemokines remain highly detectable in the BALF of steroid-resistant COVID-19-ARDS, arguing for new multi-targeted therapeutics in COVID-19-ARDS. The gene discussed is IL1B; the disease is acute respiratory distress syndrome.